百潤股份(002568.SZ):目前烈酒(威士忌)陳釀熟成項目已基本完成
格隆匯6月6日丨百潤股份(002568.SZ)近日在接待機構投資者調研時表示,公司2017年起佈局烈酒業務,崍州蒸餾廠已於2021年10月灌注第一批陳釀桶酒。公司重點關注麥芽威士忌、調和威士忌的品牌孵化和產品開發,確定了威士忌產品品類矩陣及價格帶策略,進行了多渠道、多場景戰略佈局。
目前烈酒(威士忌)陳釀熟成項目已基本完成,麥芽威士忌陳釀熟成項目正在按計劃推進,烈酒品牌文化體驗中心預計於2024年底建成對外開放。公司已灌注陳釀威士忌30餘萬桶,未來會按節奏持續投入,增加威士忌桶陳數量。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.